Zhejiang Hisoar Pharmaceutical (002099.SZ) announced a forecasted net loss of 250-350 million yuan in 2024.
21/01/2025
GMT Eight
Zhejiang Hisoar Pharmaceutical (002099.SZ) announced that the company expects a net loss attributable to shareholders of the listed company of 250 million to 350 million yuan for the year 2024.